Trial intelligence / Profile preview

Tranexamic Acid in High-Risk Cesarean Sections

NCT03820206Completed

Sponsor
Cairo University
Start
Jan 2019
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in intraoperative hemorrhage (2 arms), sponsored by Cairo University. Primary endpoint: Estimated blood loss. Started Jan 2019; status: completed.

02

Drugs

tranexamic acid
03

Conditions

intraoperative hemorrhage

Beyond the preview

Go deeper on NCT03820206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03820206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call